KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $39.2 million.

  • Edwards Lifesciences' Depreciation & Amortization (CF) rose 1362.32% to $39.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $156.5 million, marking a year-over-year increase of 482.25%. This contributed to the annual value of $155.2 million for FY2024, which is 710.84% up from last year.
  • Per Edwards Lifesciences' latest filing, its Depreciation & Amortization (CF) stood at $39.2 million for Q3 2025, which was up 1362.32% from $38.1 million recorded in Q2 2025.
  • Edwards Lifesciences' Depreciation & Amortization (CF)'s 5-year high stood at $42.6 million during Q4 2024, with a 5-year trough of $32.4 million in Q1 2021.
  • In the last 5 years, Edwards Lifesciences' Depreciation & Amortization (CF) had a median value of $35.8 million in 2021 and averaged $36.2 million.
  • In the last 5 years, Edwards Lifesciences' Depreciation & Amortization (CF) skyrocketed by 4612.24% in 2021 and then plummeted by 650.41% in 2024.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Depreciation & Amortization (CF) stood at $33.0 million in 2021, then grew by 7.27% to $35.4 million in 2022, then rose by 3.67% to $36.7 million in 2023, then rose by 16.08% to $42.6 million in 2024, then fell by 7.98% to $39.2 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $39.2 million for Q3 2025, versus $38.1 million for Q2 2025 and $36.6 million for Q1 2025.